DE3607897A1 - Verfahren zur herstellung einer chemisch modifizierten hyaluronsaeurezubereitung - Google Patents

Verfahren zur herstellung einer chemisch modifizierten hyaluronsaeurezubereitung

Info

Publication number
DE3607897A1
DE3607897A1 DE19863607897 DE3607897A DE3607897A1 DE 3607897 A1 DE3607897 A1 DE 3607897A1 DE 19863607897 DE19863607897 DE 19863607897 DE 3607897 A DE3607897 A DE 3607897A DE 3607897 A1 DE3607897 A1 DE 3607897A1
Authority
DE
Germany
Prior art keywords
hyaluronic acid
water
solvent
chemically modified
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19863607897
Other languages
German (de)
English (en)
Other versions
DE3607897C2 (enExample
Inventor
Endre A. Ft. Lee N.J. Balazs
Philip Brooklyn N.Y. Band
Adelya Fairview N.J. Leshchiner
Adolf Leshchiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Biosurgery Inc
Original Assignee
Biomatrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomatrix Inc filed Critical Biomatrix Inc
Publication of DE3607897A1 publication Critical patent/DE3607897A1/de
Application granted granted Critical
Publication of DE3607897C2 publication Critical patent/DE3607897C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE19863607897 1985-03-12 1986-03-10 Verfahren zur herstellung einer chemisch modifizierten hyaluronsaeurezubereitung Granted DE3607897A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/710,929 US4713448A (en) 1985-03-12 1985-03-12 Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues

Publications (2)

Publication Number Publication Date
DE3607897A1 true DE3607897A1 (de) 1986-09-18
DE3607897C2 DE3607897C2 (enExample) 1992-02-27

Family

ID=24856100

Family Applications (3)

Application Number Title Priority Date Filing Date
DE19863607897 Granted DE3607897A1 (de) 1985-03-12 1986-03-10 Verfahren zur herstellung einer chemisch modifizierten hyaluronsaeurezubereitung
DE3645226A Expired - Lifetime DE3645226C2 (enExample) 1985-03-12 1986-03-10
DE3645191A Expired - Lifetime DE3645191C2 (enExample) 1985-03-12 1986-03-10

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE3645226A Expired - Lifetime DE3645226C2 (enExample) 1985-03-12 1986-03-10
DE3645191A Expired - Lifetime DE3645191C2 (enExample) 1985-03-12 1986-03-10

Country Status (12)

Country Link
US (1) US4713448A (enExample)
JP (2) JPS61207401A (enExample)
AU (1) AU560956B2 (enExample)
BE (1) BE904357A (enExample)
CA (1) CA1276143C (enExample)
CH (1) CH670092A5 (enExample)
DE (3) DE3607897A1 (enExample)
FR (1) FR2582002B1 (enExample)
GB (1) GB2172295B (enExample)
IT (1) IT1191981B (enExample)
NL (1) NL186576C (enExample)
SE (1) SE468830B (enExample)

Families Citing this family (159)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5099013A (en) * 1985-03-12 1992-03-24 Biomatrix, Inc, Hylan preparation and method of recovery thereof from animal tissues
US4879375A (en) * 1985-05-09 1989-11-07 Hill David Cullis Preparation of hyaluronic acid from synovial fluid
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
EP0224987B1 (en) * 1985-11-29 1992-04-15 Biomatrix, Inc. Drug delivery systems based on hyaluronan, derivatives thereof and their salts and method of producing same
SE452469B (sv) * 1986-06-18 1987-11-30 Pharmacia Ab Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
AU610512B2 (en) * 1986-12-11 1991-05-23 Biomatrix Incorporated Improved hyaluronate-poly (ethylene oxide) mixtures
GB8713662D0 (en) * 1987-06-11 1987-07-15 Skandigen Ab Hyaluronic acid derivatives
US6174999B1 (en) 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US6610669B1 (en) 1987-09-18 2003-08-26 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
AU619760B2 (en) * 1987-12-10 1992-02-06 Genzyme Biosurgery Corporation Hylan preparation and method of recovery thereof from animal tissues
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
US5356883A (en) * 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5246698A (en) * 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5219360A (en) * 1991-05-10 1993-06-15 Fortis Research Corporation Mammary prosthesis fill and method of making same
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
CA2061567C (en) * 1992-02-20 1998-02-03 Rudolf E. Falk Use of hyaluronic acid to repair ischemia reperfusion damage
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
IT1260154B (it) * 1992-07-03 1996-03-28 Lanfranco Callegaro Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
US5690961A (en) 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5612321A (en) * 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
CA2273852C (en) 1996-12-06 2009-09-29 Amgen Inc. Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US6630457B1 (en) 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.
US20040048021A1 (en) * 1999-03-19 2004-03-11 Wan Barbara Y. F. Surface modification of substrates
US6610666B1 (en) 1999-11-08 2003-08-26 Bio-Hyos Ab Hyaluronan product and process for manufacturing thereof
US6521223B1 (en) 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
KR100375299B1 (ko) 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
WO2002068383A2 (en) * 2001-02-22 2002-09-06 Anika Therapeutics, Inc. Thiol-modified hyaluronan
KR100514582B1 (ko) * 2001-09-05 2005-09-13 한스바이오메드 주식회사 생체복원물질의 제조방법
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
US7186232B1 (en) * 2002-03-07 2007-03-06 Glaukoa Corporation Fluid infusion methods for glaucoma treatment
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
CN101134119A (zh) 2002-05-24 2008-03-05 血管技术国际股份公司 用于涂覆医用植入物的组合物和方法
AU2003299509A1 (en) * 2002-06-21 2004-05-13 University Of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
CA2496121C (en) * 2002-08-16 2010-03-30 Yoshiaki Miyata Stable formulations of hyaluronic acid for use in the therapeutic treatment of arthropathy
KR20040022760A (ko) * 2002-09-05 2004-03-18 주식회사 오스코텍 닭벼슬로부터 고순도 히아루론산의 추출방법
US6946551B2 (en) * 2003-03-12 2005-09-20 New Life Resources, Llc Preparation of hyaluronic acid from eggshell membrane
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050158356A1 (en) * 2003-11-20 2005-07-21 Angiotech International Ag Implantable sensors and implantable pumps and anti-scarring agents
US20080176205A1 (en) * 2003-12-04 2008-07-24 University Of Utah Research Foundation Process and Formulation to Improve Viability of Stored Cells and Tissue
US7625581B2 (en) * 2003-12-19 2009-12-01 Ethicon, Inc. Tissue scaffolds for use in muscoloskeletal repairs
US7091191B2 (en) * 2003-12-19 2006-08-15 Ethicon, Inc. Modified hyaluronic acid for use in musculoskeletal tissue repair
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
BRPI0418309B8 (pt) * 2003-12-30 2021-05-25 Genzyme Corp "géis coesos de hialuronado e/ou hilano reticulados, processo para a preparação dos mesmos, bem como composições e dispositivos compreendendo os referidos géis".
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
CA2567532C (en) * 2004-05-20 2013-10-01 Mentor Corporation Methods for making injectable polymer hydrogels
US7002007B2 (en) * 2004-05-28 2006-02-21 Calcigen Corporation Production of high molecular weight hyaluronates
ITMI20041373A1 (it) 2004-07-09 2004-10-09 Lima Lto S P A N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
EP1817347B1 (en) * 2004-11-24 2017-05-17 Albumedix A/S Method of cross-linking hyaluronic acid with divinylsulfone
CN103860582A (zh) 2004-12-30 2014-06-18 建新公司 用于关节内粘弹性补充的方案
ITPD20050056A1 (it) 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US20070202084A1 (en) 2005-12-14 2007-08-30 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
WO2007070547A2 (en) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
EP1991587B1 (en) 2006-03-07 2013-07-24 ProChon Biotech Ltd. Hydrazido derivatives of hyaluronic acid
ITPD20060219A1 (it) 2006-05-31 2007-12-01 Fidia Farmaceutici Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi
EP2107913B1 (en) * 2006-12-22 2012-02-15 Croma-Pharma Gesellschaft m.b.H. Use of thiolated polysaccharides for tissue augmentation
WO2008081463A2 (en) * 2007-01-04 2008-07-10 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
CA2687990A1 (en) 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
US8658148B2 (en) 2007-06-22 2014-02-25 Genzyme Corporation Chemically modified dendrimers
US20110077737A1 (en) * 2007-07-30 2011-03-31 Allergan, Inc. Tunably Crosslinked Polysaccharide Compositions
US8318695B2 (en) 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
RU2501811C2 (ru) * 2007-11-13 2013-12-20 Био-Текнолоджи Дженерал (Изрейел) Лтд. Способ стерилизации посредством фильтрации разбавленных вязкоэластичных биополимеров (варианты)
PT2818184T (pt) 2007-11-16 2019-01-28 Aclaris Therapeutics Inc Composições e métodos para o tratamento de púrpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US9044477B2 (en) 2007-12-12 2015-06-02 Allergan, Inc. Botulinum toxin formulation
US9161970B2 (en) 2007-12-12 2015-10-20 Allergan, Inc. Dermal filler
WO2009077399A1 (en) * 2007-12-19 2009-06-25 Evonik Goldschmidt Gmbh Crosslinked hyaluronic acid in emulsion
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
CA2735173C (en) 2008-09-02 2017-01-10 Tautona Group Lp Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
WO2010038231A1 (en) 2008-10-02 2010-04-08 L.R.R.& D. Ltd. Interface layer wound dressing
CN101721349B (zh) 2008-10-16 2011-07-20 常州百瑞吉生物医药有限公司 可注射原位交联水凝胶及其制备方法和用途
CZ301555B6 (cs) 2008-11-06 2010-04-14 Cpn S. R. O. Zpusob prípravy DTPA sítovaných derivátu kyseliny hyaluronové a jejich modifikace
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US8273725B2 (en) 2009-09-10 2012-09-25 Genzyme Corporation Stable hyaluronan/steroid formulation
CZ2009836A3 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US8586562B2 (en) 2010-03-12 2013-11-19 Allergan Industrie, Sas Fluid compositions for improving skin conditions
EP4062950A1 (en) 2010-03-22 2022-09-28 Allergan, Inc. Syringe comprising dermal filler for soft tissue augmentation
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
CZ302994B6 (cs) 2010-12-31 2012-02-08 Cpn S.R.O. Hyaluronová vlákna, zpusob jejich prípravy a použití
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
RU2624239C2 (ru) 2011-06-03 2017-07-03 Аллерган, Инк. Составы кожного наполнителя, включая антиоксиданты
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
DE102011077393A1 (de) * 2011-06-10 2012-12-13 Johannes Reinmüller Antiinfektives Mittel
US10865383B2 (en) 2011-07-12 2020-12-15 Lineage Cell Therapeutics, Inc. Methods and formulations for orthopedic cell therapy
RU2613887C2 (ru) 2011-08-10 2017-03-21 Гликорес 2000 С.Р.Л. Устойчивый к расщеплению сшитый низкомолекулярный гиалуронат
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
FR2983483B1 (fr) 2011-12-02 2014-11-14 Vivacy Lab Procede de substitution et reticulation simultanees d'un polysaccharide via ses fonctions hydroxyles
CZ303879B6 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
KR101240518B1 (ko) 2012-03-26 2013-03-11 주식회사 제네웰 생체 적합성 고분자를 이용한 이식용 재료
ITPD20120098A1 (it) 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
EP2831237B1 (en) 2012-03-30 2017-11-29 The Board of Regents of the University of Oklahoma High molecular weight heparosan polymers and methods of production and use thereof
ITPD20120173A1 (it) 2012-05-31 2013-12-01 Fidia Farmaceutici "nuovo sistema di rilascio di proteine idrofobiche"
IN2014DN10147A (enExample) * 2012-06-15 2015-08-21 Merz Pharma Gmbh & Co Kgaa
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
CN102863631B (zh) * 2012-09-29 2013-11-13 杭州嘉伟生物制品有限公司 外科整形用组织填充剂交联透明质酸钠凝胶及其制备方法
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
HK1214618A1 (zh) 2013-01-11 2016-07-29 Carbylan Therapeutics, Inc. 含有透明質酸的穩定化組合物
US9714361B2 (en) 2013-03-15 2017-07-25 Lake Region Manfacturing, Inc. Oxirane (ethylene oxide) polyurethane coatings
US9255173B2 (en) 2013-03-15 2016-02-09 Lake Region Manufacturing, Inc. Oxirane (ethylene oxide) polyurethane coatings
CZ2014150A3 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
RU2715234C2 (ru) 2015-02-13 2020-02-26 Аллерган Эндюстри, Сас Имплантаты для моделирования, увеличения или коррекции частей лица, например подбородка
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ2015398A3 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
KR20170090965A (ko) * 2016-01-29 2017-08-08 한미약품 주식회사 복합 히알루론산 가교물 및 그 제조방법
EP3415586B1 (en) 2016-02-12 2022-11-30 Laimu Corporation Wound treatment agent and method for producing same
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
AU2018216540B2 (en) 2017-02-02 2021-02-18 Amtixbio Co., Ltd. Hydrogel using, as substrate, hyaluronic acid derivative modified with gallol group and use thereof
BR112021004771A2 (pt) 2018-09-13 2021-11-09 Allergan Inc Composições de ácido hialurônico-toxina clostridial
US10899944B2 (en) 2018-10-29 2021-01-26 Lake Region Manufacturing, Inc. Polyurethane urea-containing adipic acid dihydrazide where active hydrogens react with the epoxy group found on glycidol to form a diol
KR102400586B1 (ko) 2018-12-07 2022-05-23 한미약품 주식회사 히알루론산 가교물, 히알루론산 수화 겔 및 이들의 제조방법
US12090248B2 (en) 2018-12-07 2024-09-17 Hanmi Pharm. Co., Ltd. Crosslinked hyaluronic acid, hyaluronic acid hydrogel, and method for producing crosslinked hyaluronic acid and hyaluronic acid hydrogel
WO2022147084A1 (en) 2020-12-30 2022-07-07 Convatec Technologies Inc. Surface treatment system and method for subcutaneous device
KR20220106283A (ko) 2021-01-22 2022-07-29 (주)앰틱스바이오 자가 가교형 히알루론산 유도체 기반 창상피복재
WO2023104843A1 (de) 2021-12-09 2023-06-15 Beiersdorf Ag Topisch applizierbare zubereitung zur verbesserung des hautzustandes
DE102022202547A1 (de) 2021-12-09 2023-06-15 Beiersdorf Aktiengesellschaft Topisch applizierbare Zubereitung zur Verbesserung des Hautzustandes
IT202100032111A1 (it) 2021-12-22 2023-06-22 Fidia Farm Spa Nuovi sostituti biocompatibili dell’umor vitreo
DE102023201536A1 (de) 2023-02-21 2024-08-22 Beiersdorf Aktiengesellschaft Körpermilch
DE102023201528A1 (de) 2023-02-21 2024-08-22 Beiersdorf Aktiengesellschaft Körpermilch
EP4701742A1 (de) 2023-04-27 2026-03-04 Beiersdorf AG Retinolhaltige kosmetische zubereitung mit guter hautverträglichkeit
DE102023203936A1 (de) 2023-04-27 2024-10-31 Beiersdorf Aktiengesellschaft Retinolhaltige kosmetische Zubereitung mit guter Hautverträglichkeit
WO2024223515A1 (de) 2023-04-27 2024-10-31 Beiersdorf Ag Retinolhaltige kosmetische zubereitung mit guter stabilität und hautverträglichkeit
EP4701743A1 (de) 2023-04-27 2026-03-04 Beiersdorf AG Retinolhaltige kosmetische zubereitung mit guter stabilität, hautverträglichkeit und wirksamkeit
CN118812877B (zh) * 2024-06-17 2025-02-14 弘知生物科技(浙江)有限公司 一种含聚胍类高分子聚合物的长效抑菌水凝胶及制备方法
DE102024003493A1 (de) 2024-10-24 2026-04-30 Beiersdorf Aktiengesellschaft Kombination aus Retinol, Alkylamidothiazolen und Flavonoiden zur Verbesserung der Wirkstoffstabilisierung

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2627125A1 (de) * 1975-06-18 1976-12-30 Hayashibara Biochem Lab Vernetztes pullulan
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4303676A (en) 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
DE3434104A1 (de) * 1983-12-15 1985-08-29 Biomatrix Inc., Ridgefield, N.J. Wasserunloesliche zubereitung von hyaluronsaeure und verfahren dazu

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT252264B (de) * 1965-03-17 1967-02-10 Etapharm Chem Pharm Lab Ges M Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
US4048435A (en) * 1976-07-12 1977-09-13 National Starch And Chemical Corporation Method for the preparation of highly substituted granular starches
US4272522A (en) * 1979-10-15 1981-06-09 Balazs Endre A Method for stimulating phagocytic activity and synergistic compositions therefor
SU950735A1 (ru) * 1980-10-28 1982-08-15 Саратовский Ордена Трудового Красного Знамени Государственный Университет Им.Н.Г.Чернышевского Способ получени гиалуроновой кислоты
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
US4500676A (en) * 1983-12-15 1985-02-19 Biomatrix, Inc. Hyaluronate modified polymeric articles
US4487865A (en) * 1983-12-15 1984-12-11 Biomatrix, Inc. Polymeric articles modified with hyaluronate
US4629623A (en) * 1984-06-11 1986-12-16 Biomatrix, Inc. Hyaluronate-poly (ethylene oxide) compositions and cosmetic formulations thereof
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4605691A (en) * 1984-12-06 1986-08-12 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2627125A1 (de) * 1975-06-18 1976-12-30 Hayashibara Biochem Lab Vernetztes pullulan
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4141973B1 (enExample) * 1975-10-17 1989-08-08
US4303676A (en) 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
DE3434104A1 (de) * 1983-12-15 1985-08-29 Biomatrix Inc., Ridgefield, N.J. Wasserunloesliche zubereitung von hyaluronsaeure und verfahren dazu

Non-Patent Citations (23)

* Cited by examiner, † Cited by third party
Title
Analyt.Biochem. 1965, 12, 547-558
Annals Rheumatic Diseases, 1955, 15, 67-68
Arkiv for Kemi, Mineral.Geol.,1945,19A,1
BALAZS, E.A.: Healon, Wiley and Son, New York 1983,5-28
Biochem.J., 1952, 62, 31
Biochem.J., 1968, 109, 43-50
Biochem.J., 1972, 128, 1255-1263
Biochim.Biophys. Acta, 1960, 42, 472-485
Biochim.Biophys. Acta, 1962, 58, 120-122
Biochim.Biophys. Acta, 1966, 130, 112-129
Biochim.Biophys. Acta, 1981, 673, 192-196
Biopolymers, 1970, 9, 799
Carbohydr.Res., 1974, 32, 386-395
Fed.Proceed., 1958, 17, 1086-1093
Fed.Proceed., 1966, 25, 1817-1822
J.Biol.Chem., 1942, 146, 279
J.Biol.Chem., 1951, 193, 265-275
J.Biol.Chem., 1955, 216, 263-271
J.Biol.Chem., 1981, 256, 8463-8469
J.Mol.Biol., 1983, 169, 861-872
Naturforsch., 1979, 34c, 508-511
Science, 1972, 179, 560-562
WALKER, J.F.: Formaldehyde, Reinhold Publ.Corp., New York 1953, 312-317

Also Published As

Publication number Publication date
CH670092A5 (enExample) 1989-05-12
NL8600644A (nl) 1986-10-01
SE8601135D0 (sv) 1986-03-11
SE8601135L (sv) 1986-09-13
AU5289186A (en) 1986-09-18
JPS61207401A (ja) 1986-09-13
AU560956B2 (en) 1987-04-30
CA1276143C (en) 1990-11-13
SE468830B (sv) 1993-03-29
IT8619684A1 (it) 1987-09-10
AU583464B2 (en) 1989-04-27
DE3607897C2 (enExample) 1992-02-27
AU7618087A (en) 1987-10-29
NL186576C (nl) 1991-01-02
IT1191981B (it) 1988-03-31
US4713448A (en) 1987-12-15
DE3645226C2 (enExample) 1993-07-15
GB2172295B (en) 1989-01-05
GB2172295A (en) 1986-09-17
FR2582002A1 (fr) 1986-11-21
DE3645191C2 (enExample) 1992-12-10
FR2582002B1 (fr) 1988-01-15
JPH0353321B2 (enExample) 1991-08-14
JPH01198602A (ja) 1989-08-10
BE904357A (fr) 1986-06-30
IT8619684A0 (it) 1986-03-10
NL186576B (nl) 1990-08-01
GB8601304D0 (en) 1986-02-26

Similar Documents

Publication Publication Date Title
DE3645191C2 (enExample)
DE69632313T2 (de) Desorbierbare extrazelluläre matrix für rekonstruktion eines knorpelgewebes
DE3546811C2 (enExample)
DE3750793T2 (de) Verfahren zur Behandlung von Kollagen zur Erleichterung seiner Vernetzung und das so erhaltene Kollagen.
DE69711540T3 (de) Lösungsmittel-getrocknete Polysaccharidschwämme
US5099013A (en) Hylan preparation and method of recovery thereof from animal tissues
DE69129391T2 (de) Bioverträgliche, viskoelastische Gelschlämme, ihre Herstellung und Verwendung
DE68917009T2 (de) Sulfaminoderivate von Chondroitinsulfat, Dermatansulfat und Hyaluronsäure und ihre pharmakologischen Eigenschaften.
DE3125260C2 (de) Wasserhaltiges, viscoelastisches Gemisch enthaltend Hyaluronat und kosmetische Mittel enthaltend diese Gemische
US6610810B2 (en) Biopolymers obtained by solid state irradiation in an unsaturated gaseous atmosphere
WO1996030411A1 (de) Verfahren zur aktivierung von polysacchariden, danach hergestellte polysaccharide und deren verwendung
DE69115181T2 (de) Polysaccharid enthaltende Zusammensetzung oder Polysaccharid mit heparinoidaler Aktivität, Verfahren zu ihrer Herstellung und Antikoagulans welche dieses als aktives Ingredienz enthält.
DD212969A1 (de) Verfahren zur modifizierung von carboxymethylcellulose
DE3852992T2 (de) Verfahren zur Herstellung von Hylan und Hylanverbindungen.
DE212020000715U1 (de) Hydrogel auf der Basis eines vernetzten Hydroxyphenylderivats der Hyaluronsäure
DE102021209820B4 (de) Verfahren zur Herstellung eines flüssigen Cellulose-Komposits aus bakterieller Nanocellulose und Carboxymethylcellulose, Cellulose-Komposit und dessen Verwendung
DE60017802T2 (de) Hyaluronan enthaltende zusammensetzung und verfahren zu ihrer herstellung
DE918532C (de) Verfahren zur Herstellung von Polymerhomologen von Dextran
DE19954357C2 (de) Zusammensetzung, enthaltend Heteropolysaccharid und perlenförmiges quervernetztes Polysaccharid, sowie deren Verwendung für medizinische/kosmetische Zwecke
DE4242813A1 (enExample)
DE4121115B4 (de) Gemische sulfatierter Polysaccharide mit der Grundstruktur der das Heparin bildenden Polysaccharide und mit niedrigem Molekulargewicht, deren Herstellungsverfahren und Verwendung
CH254105A (de) Verfahren zur Herstellung eines völlig wasserlöslichen Polymerhomologen von Dextran.
HK1001897B (en) Method for preparing hylan and novel hylan product
CH282873A (de) Verfahren zur Herstellung von hochmolekularen Dextranabbauprodukten praktisch einheitlicher Molekülgrösse für pharmazeutische Zwecke.

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3645191

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3645191

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3645226

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3645226

AH Division in

Ref country code: DE

Ref document number: 3645191

Format of ref document f/p: P

Ref country code: DE

Ref document number: 3645226

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
AH Division in

Ref country code: DE

Ref document number: 3645191

Format of ref document f/p: P

AH Division in

Ref country code: DE

Ref document number: 3645226

Format of ref document f/p: P

8327 Change in the person/name/address of the patent owner

Owner name: GENZYME BIOSURGERY CORPORATION, CAMBRIDGE, MASS.,